{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:32:08Z","timestamp":1793302328427,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Oslo","id":[{"id":"https:\/\/ror.org\/01xtthb56","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>This integrated end-to-end protocol provides a comprehensive and efficient workflow for the generation, screening and expansion of high-quality monoclonal iPSC lines after CRISPR-Cas9 editing.<\/jats:p>","DOI":"10.1007\/s12015-026-11221-6","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T04:24:43Z","timestamp":1788150283000},"page":"3790-3816","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From Design to Single-Cell Cloning: A Complete RNP-Based CRISPR-Cas9 Protocol for Precision Gene Correction in Human iPSCs"],"prefix":"10.1007","volume":"22","author":[{"given":"Giacomo","family":"Roman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut H.","family":"Lauritzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"Smolkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runar","family":"Almaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Morten","family":"Sandset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Stavik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth J.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Chollet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"11221_CR1","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi, K., & Yamanaka, S. (2006). Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell, 126, 663\u2013676. https:\/\/doi.org\/10.1016\/j.cell.2006.07.024","journal-title":"Cell"},{"key":"11221_CR2","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007). Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell, 131, 861\u2013872. https:\/\/doi.org\/10.1016\/j.cell.2007.11.019","journal-title":"Cell"},{"key":"11221_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2025.01.015","author":"J Takahashi","year":"2025","unstructured":"Takahashi, J. (2025). IPSC-based cell replacement therapy: From basic research to clinical application. Cytotherapy. https:\/\/doi.org\/10.1016\/j.jcyt.2025.01.015","journal-title":"Cytotherapy"},{"key":"11221_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01809-0","author":"J Cerneckis","year":"2024","unstructured":"Cerneckis, J., Cai, H., & Shi, Y. (2024). Induced pluripotent stem cells (iPSCs): Molecular mechanisms of induction and applications. Nature Publishing Group. https:\/\/doi.org\/10.1038\/s41392-024-01809-0","journal-title":"Nature Publishing Group"},{"key":"11221_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1188905","author":"Z Xu","year":"2023","unstructured":"Xu, Z., Yang, J., Xin, X., Liu, C., Li, L., Mei, X., & Li, M. (2023). Merits and challenges of iPSC-derived organoids for clinical applications. Frontiers Media SA. https:\/\/doi.org\/10.3389\/fcell.2023.1188905","journal-title":"Frontiers Media SA"},{"key":"11221_CR6","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1038\/s12276-023-01074-1","volume":"55","author":"SP Harrison","year":"2023","unstructured":"Harrison, S. P., Siller, R., Tanaka, Y., Chollet, M. E., de la Morena-Barrio, M. E., Xiang, Y., Patterson, B., Andersen, E., Bravo-P\u00e9rez, C., Kempf, H., et al. (2023). Scalable production of tissue-like vascularized liver organoids from human PSCs. Experimental and Molecular Medicine, 55, 2005\u20132024. https:\/\/doi.org\/10.1038\/s12276-023-01074-1","journal-title":"Experimental and Molecular Medicine"},{"key":"11221_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1094249","author":"G Roman","year":"2023","unstructured":"Roman, G., Stavik, B., Lauritzen, K. H., Sandset, P. M., Harrison, S. P., Sullivan, G. J., & Chollet, M. E. (2023). iPSC-derived liver organoids and inherited bleeding disorders: Potential and future perspectives. Frontiers Media S A. https:\/\/doi.org\/10.3389\/fphys.2023.1094249","journal-title":"Frontiers Media S A"},{"key":"11221_CR8","doi-asserted-by":"publisher","unstructured":"Doudna, J. A., & Charpentier, E. (2014). The new frontier of genome engineering with CRISPR-Cas9, https:\/\/doi.org\/10.1126\/science.1258096","DOI":"10.1126\/science.1258096"},{"key":"11221_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.01.042","author":"M Pacesa","year":"2024","unstructured":"Pacesa, M., Pelea, O., & Jinek, M. (2024). Past, present, and future of CRISPR genome editing technologies. Cell. https:\/\/doi.org\/10.1016\/j.cell.2024.01.042","journal-title":"Cell"},{"key":"11221_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/J.STEM.2016.04.013","volume":"18","author":"D Hockemeyer","year":"2016","unstructured":"Hockemeyer, D., & Jaenisch, R. (2016). Induced Pluripotent Stem Cells Meet Genome Editing. Cell Stem Cell, 18, 573\u2013586. https:\/\/doi.org\/10.1016\/J.STEM.2016.04.013","journal-title":"Cell Stem Cell"},{"key":"11221_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-020-00276-2","author":"C De Masi","year":"2020","unstructured":"De Masi, C., Spitalieri, P., Murdocca, M., Novelli, G., & Sangiuolo, F. (2020). Application of CRISPR\/Cas9 to human-induced pluripotent stem cells: From gene editing to drug discovery. Human Genomics. https:\/\/doi.org\/10.1186\/s40246-020-00276-2","journal-title":"Human Genomics"},{"key":"11221_CR12","doi-asserted-by":"crossref","unstructured":"Wright, A. V., Nu\u00f1ez, J. K., & Doudna, J. A. (2016). Biology and Applications of CRISPR Systems. Harnessing Nature\u2019s Toolbox for Genome Engineering (Cell).","DOI":"10.1016\/j.cell.2015.12.035"},{"key":"11221_CR13","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nrmicro3569","volume":"13","author":"KS Makarova","year":"2015","unstructured":"Makarova, K. S., Wolf, Y. I., Alkhnbashi, O. S., Costa, F., Shah, S. A., Saunders, S. J., Barrangou, R., Brouns, S. J. J., Charpentier, E., Haft, D. H., et al. (2015). An updated evolutionary classification of CRISPR-Cas systems. Nature Reviews Microbiology, 13, 722\u2013736. https:\/\/doi.org\/10.1038\/nrmicro3569","journal-title":"Nature Reviews Microbiology"},{"key":"11221_CR14","doi-asserted-by":"publisher","unstructured":"Ghanta, K. S., Chen, Z., Mir, A., Dokshin, G. A., Krishnamurthy, P. M., Yoon, Y., Gallant, J., Xu, P., Zhang, X. O., Ozturk, A., et al. (2021). 5\u2032 modifications improve potency and efficacy of dna donors for precision genome editing. Elife, 10. https:\/\/doi.org\/10.7554\/eLife.72216","DOI":"10.7554\/eLife.72216"},{"key":"11221_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.omtn.2017.02.006","volume":"7","author":"F Song","year":"2017","unstructured":"Song, F., & Stieger, K. (2017). Optimizing the DNA Donor Template for Homology-Directed Repair of Double-Strand Breaks. Mol Ther Nucleic Acids, 7, 53\u201360. https:\/\/doi.org\/10.1016\/j.omtn.2017.02.006","journal-title":"Mol Ther Nucleic Acids"},{"key":"11221_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20358-5","author":"Q Guo","year":"2018","unstructured":"Guo, Q., Mintier, G., Ma-Edmonds, M., Storton, D., Wang, X., Xiao, X., Kienzle, B., Zhao, D., & Feder, J. N. (2018). Cold shock\u201d increases the frequency of homology directed repair gene editing in induced pluripotent stem cells. Scientific Reports. https:\/\/doi.org\/10.1038\/s41598-018-20358-5","journal-title":"Scientific Reports"},{"key":"11221_CR17","doi-asserted-by":"crossref","unstructured":"Liu, M., Rehman, S., Tang, X., Gu, K., Fan, Q., Chen, D., & Ma, W. (2019). Methodologies for improving HDR efficiency. Frontiers Media S.A.","DOI":"10.3389\/fgene.2018.00691"},{"key":"11221_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ymeth.2019.06.016","volume":"164\u2013165","author":"WC Skarnes","year":"2019","unstructured":"Skarnes, W. C., Pellegrino, E., & McDonough, J. A. (2019). Improving homology-directed repair efficiency in human stem cells. Methods, 164\u2013165, 18\u201328.","journal-title":"Methods"},{"key":"11221_CR19","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nbt.3190","volume":"33","author":"T Maruyama","year":"2015","unstructured":"Maruyama, T., Dougan, S. K., Truttmann, M. C., Bilate, A. M., Ingram, J. R., & Ploegh, H. L. (2015). Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Nature Biotechnology, 33, 538\u2013542. https:\/\/doi.org\/10.1038\/nbt.3190","journal-title":"Nature Biotechnology"},{"key":"11221_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33244-x","volume":"8","author":"A Idoko-Akoh","year":"2018","unstructured":"Idoko-Akoh, A., Taylor, L., Sang, H. M., & McGrew, M. J. (2018). High fidelity CRISPR\/Cas9 increases precise monoallelic and biallelic editing events in primordial germ cells. Scientific Reports, 8, Article 15126. https:\/\/doi.org\/10.1038\/s41598-018-33244-x","journal-title":"Scientific Reports"},{"key":"11221_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-98965-y","author":"MS Schubert","year":"2021","unstructured":"Schubert, M. S., Thommandru, B., Woodley, J., Turk, R., Yan, S., Kurgan, G., McNeill, M. S., & Rettig, G. R. (2021). Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair. Scientific Reports. https:\/\/doi.org\/10.1038\/s41598-021-98965-y","journal-title":"Scientific Reports"},{"key":"11221_CR22","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1016\/j.stemcr.2023.10.013","volume":"18","author":"A Namipashaki","year":"2023","unstructured":"Namipashaki, A., Pugsley, K., Liu, X., Abrehart, K., Lim, S. M., Sun, G., Herold, M. J., Polo, J. M., Bellgrove, M. A., & Hawi, Z. (2023). Integration of xeno-free single-cell cloning in CRISPR-mediated DNA editing of human iPSCs improves homogeneity and methodological efficiency of cellular disease modeling. Stem Cell Reports, 18, 2515\u20132527. https:\/\/doi.org\/10.1016\/j.stemcr.2023.10.013","journal-title":"Stem Cell Reports"},{"key":"11221_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2017.05.009","author":"S Yumlu","year":"2017","unstructured":"Yumlu, S., Stumm, J., Bashir, S., Dreyer, A. K., Lisowski, P., Danner, E., & K\u00fchn, R. (2017). Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR\/Cas9. Methods. https:\/\/doi.org\/10.1016\/j.ymeth.2017.05.009","journal-title":"Methods"},{"key":"11221_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41596-022-00753-z","volume":"18","author":"CA Tristan","year":"2023","unstructured":"Tristan, C. A., Hong, H., Jethmalani, Y., Chen, Y., Weber, C., Chu, P. H., Ryu, S., Jovanovic, V. M., Hur, I., Voss, T. C., et al. (2023). Efficient and safe single-cell cloning of human pluripotent stem cells using the CEPT cocktail. Nature Protocols, 18, 58\u201380. https:\/\/doi.org\/10.1038\/s41596-022-00753-z","journal-title":"Nature Protocols"},{"key":"11221_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2023.102406","author":"KA Ludwik","year":"2023","unstructured":"Ludwik, K. A., Telugu, N., Schommer, S., Stachelscheid, H., & Diecke, S. (2023). ASSURED-optimized CRISPR protocol for knockout\/SNP knockin in hiPSCs. STAR Protocols. https:\/\/doi.org\/10.1016\/j.xpro.2023.102406","journal-title":"STAR Protocols"},{"key":"11221_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2017.04.003","author":"MA DeWitt","year":"2017","unstructured":"DeWitt, M. A., Corn, J. E., & Carroll, D. (2017). Genome editing via delivery of Cas9 ribonucleoprotein. Methods. https:\/\/doi.org\/10.1016\/j.ymeth.2017.04.003","journal-title":"Methods"},{"key":"11221_CR27","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/s41591-018-0137-0","volume":"24","author":"CA Vakulskas","year":"2018","unstructured":"Vakulskas, C. A., Dever, D. P., Rettig, G. R., Turk, R., Jacobi, A. M., Collingwood, M. A., Bode, N. M., McNeill, M. S., Yan, S., Camarena, J., et al. (2018). A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells. Nature Medicine, 24, 1216\u20131224. https:\/\/doi.org\/10.1038\/s41591-018-0137-0","journal-title":"Nature Medicine"},{"key":"11221_CR28","doi-asserted-by":"publisher","unstructured":"Jacobi, A. M., Rettig, G. R., Turk, R., Collingwood, M. A., Zeiner, S. A., Quadros, R. M., Harms, D. W., Bonthuis, P. J., Gregg, C., Ohtsuka, M. (2017). Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes. Methods 121\u2013122, 16\u201328. https:\/\/doi.org\/10.1016\/j.ymeth.2017.03.021","DOI":"10.1016\/j.ymeth.2017.03.021"},{"key":"11221_CR29","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2025.288046","author":"G Roman","year":"2026","unstructured":"Roman, G., Lauritzen, K. H., Harrison, S. P., Bhattacharya, A., Andresen, M. S., Mowinckel, M.-C., Smolkova, B., Henriksson, C. E., Glosli, H., Iversen, N., et al. (2026). Ex vivo correction of severe coagulation factor VII deficiency in patient-derived 3D liver organoids. Haematologica. https:\/\/doi.org\/10.3324\/haematol.2025.288046","journal-title":"Haematologica"},{"key":"11221_CR30","unstructured":"Integrated, D. N. A., & Technologies (IDT). (2022). Improved methods for CRISPR-Cas9 homology-directed repair (HDR) for efficient, high-fidelity genome editing. Integrated DNA Technologies (IDT)."},{"key":"11221_CR31","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41592-021-01126-2","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen, Y., Tristan, C. A., Chen, L., Jovanovic, V. M., Malley, C., Chu, P. H., Ryu, S., Deng, T., Ormanoglu, P., Tao, D., et al. (2021). A versatile polypharmacology platform promotes cytoprotection and viability of human pluripotent and differentiated cells. Nature Methods, 18, 528\u2013541. https:\/\/doi.org\/10.1038\/s41592-021-01126-2","journal-title":"Nature Methods"},{"key":"11221_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nbt.3117","volume":"33","author":"SQ Tsai","year":"2015","unstructured":"Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015). GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nature Biotechnology, 33, 187\u2013198. https:\/\/doi.org\/10.1038\/nbt.3117","journal-title":"Nature Biotechnology"},{"key":"11221_CR33","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nmeth.4278","volume":"14","author":"SQ Tsai","year":"2017","unstructured":"Tsai, S. Q., Nguyen, N. T., Malagon-Lopez, J., Topkar, V. V., Aryee, M. J., & Joung, J. K. (2017). CIRCLE-seq: A highly sensitive in vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets. Nature Methods, 14, 607\u2013614. https:\/\/doi.org\/10.1038\/nmeth.4278","journal-title":"Nature Methods"},{"key":"11221_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-025-02948-7","author":"CR Lazzarotto","year":"2026","unstructured":"Lazzarotto, C. R., Katta, V., Li, Y., Manquen, G., Wood, R. K., Chyr, J., Urbina, E., Matsubara, A., Lee, G. H., Wu, X., et al. (2026). Sensitive and unbiased genome-wide profiling of base-editor-induced off-target activity using CHANGE-seq-BE. Nature Biotechnology. https:\/\/doi.org\/10.1038\/s41587-025-02948-7","journal-title":"Nature Biotechnology"},{"key":"11221_CR35","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1038\/s41596-018-0055-0","volume":"13","author":"CR Lazzarotto","year":"2018","unstructured":"Lazzarotto, C. R., Nguyen, N. T., Tang, X., Malagon-Lopez, J., Guo, J. A., Aryee, M. J., Joung, J. K., & Tsai, S. Q. (2018). Defining CRISPR\u2013Cas9 genome-wide nuclease activities with CIRCLE-seq. Nature Protocols, 13, 2615\u20132642. https:\/\/doi.org\/10.1038\/s41596-018-0055-0","journal-title":"Nature Protocols"},{"key":"11221_CR36","doi-asserted-by":"publisher","unstructured":"Inen, J., Han, C. M., Farrel, D. M., Bilousova, G., & Kogut, I. (2024). CIRCLE-Seq for Interrogation of Off-Target Gene Editing. J. Vis. Exp. 2024-Novem, https:\/\/doi.org\/10.3791\/67069. https:\/\/doi.org\/10.3791\/67069.","DOI":"10.3791\/67069"},{"key":"11221_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-021-00626-x","author":"NL Malinin","year":"2021","unstructured":"Malinin, N. L., Lee, G. H., Lazzarotto, C. R., Li, Y., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Iafrate, A. J., Le, L. P., et al. (2021). Defining genome-wide CRISPR\u2013Cas genome-editing nuclease activity with GUIDE-seq. Nature Protocols. https:\/\/doi.org\/10.1038\/s41596-021-00626-x","journal-title":"Nature Protocols"},{"key":"11221_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-024-60766-4","author":"A Singh","year":"2024","unstructured":"Singh, A., Smedley, G. D., Rose, J. G., Fredriksen, K., Zhang, Y., Li, L., & Yuan, S. H. (2024). A high efficiency precision genome editing method with CRISPR in iPSCs. Scientific Reports. https:\/\/doi.org\/10.1038\/S41598-024-60766-4","journal-title":"Scientific Reports"},{"key":"11221_CR39","doi-asserted-by":"publisher","unstructured":"\u2019t Groen, S. L. M., Broeders, M., Pijnappel, W. W. M. P. CRISPR-Cas9-Mediated Gene Editing in Human Induced Pluripotent Stem Cells. In (, & Humana, New York, NY) (Eds.). (2021). pp. 235\u2013264. https:\/\/doi.org\/10.1007\/978-1-0716-1657-4_16","DOI":"10.1007\/978-1-0716-1657-4_16"},{"key":"11221_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-022-00541-1","author":"PJ Chen","year":"2023","unstructured":"Chen, P. J., & Liu, D. R. (2023). Prime editing for precise and highly versatile genome manipulation. Nature Reviews Genetics. https:\/\/doi.org\/10.1038\/s41576-022-00541-1","journal-title":"Nature Reviews Genetics"},{"key":"11221_CR41","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1182\/blood.2022018252","volume":"141","author":"C Li","year":"2023","unstructured":"Li, C., Georgakopoulou, A., Newby, G. A., Chen, P. J., Everette, K. A., Paschoudi, K., Vlachaki, E., Gil, S., Anderson, A. K., Koob, T., et al. (2023). In vivo HSC prime editing rescues sickle cell disease in a mouse model. Blood, 141, 2085\u20132099. https:\/\/doi.org\/10.1182\/blood.2022018252","journal-title":"Blood"},{"key":"11221_CR42","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41591-020-0790-y","volume":"26","author":"J Zeng","year":"2020","unstructured":"Zeng, J., Wu, Y., Ren, C., Bonanno, J., Shen, A. H., Shea, D., Gehrke, J. M., Clement, K., Luk, K., Yao, Q., et al. (2020). Therapeutic base editing of human hematopoietic stem cells. Nature Medicine, 26, 535\u2013541. https:\/\/doi.org\/10.1038\/s41591-020-0790-y","journal-title":"Nature Medicine"},{"key":"11221_CR43","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.944204","author":"DV Parums","year":"2024","unstructured":"Parums, D. V. (2024). Editorial: First Regulatory Approvals for CRISPRCas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent b-Thalassemia. Medical Science Monitor. https:\/\/doi.org\/10.12659\/MSM.944204","journal-title":"Medical Science Monitor"},{"key":"11221_CR44","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016). Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature, 533, 420\u2013424. https:\/\/doi.org\/10.1038\/nature17946","journal-title":"Nature"},{"key":"11221_CR45","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017). Programmable base editing of T to G C in genomic DNA without DNA cleavage. Nature, 551, 464\u2013471. https:\/\/doi.org\/10.1038\/nature24644","journal-title":"Nature"},{"key":"11221_CR46","doi-asserted-by":"publisher","unstructured":"Nishida, K., Arazoe, T., Yachie, N., Banno, S., Kakimoto, M., Tabata, M., Mochizuki, M., Miyabe, A., Araki, M., Hara, K. Y., et al. (2016). Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science (80-), 353. https:\/\/doi.org\/10.1126\/science.aaf8729","DOI":"10.1126\/science.aaf8729"},{"key":"11221_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone, A. V., Randolph, P. B., Davis, J. R., Sousa, A. A., Koblan, L. W., Levy, J. M., Chen, P. J., Wilson, C., Newby, G. A., Raguram, A., et al. (2019). Search-and-replace genome editing without double-strand breaks or donor DNA. Nature, 576, 149\u2013157. https:\/\/doi.org\/10.1038\/s41586-019-1711-4","journal-title":"Nature"},{"key":"11221_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0084-6","author":"EM Porto","year":"2020","unstructured":"Porto, E. M., Komor, A. C., Slaymaker, I. M., & Yeo, G. W. (2020). Base editing: Advances and therapeutic opportunities. Nature Research. https:\/\/doi.org\/10.1038\/s41573-020-0084-6","journal-title":"Nature Research"},{"key":"11221_CR49","doi-asserted-by":"publisher","unstructured":"Mishra, R., Joshi, R. K., & Zhao, K. (2020). Base editing in crops: current advances, limitations and future implications. Blackwell Publishing Ltd. https:\/\/doi.org\/10.1111\/pbi.13225","DOI":"10.1111\/pbi.13225"},{"key":"11221_CR50","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1101\/gr.171322.113","volume":"24","author":"S Kim","year":"2014","unstructured":"Kim, S., Kim, D., Cho, S. W., Kim, J., & Kim, J. S. (2014). Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Research, 24, 1012\u20131019. https:\/\/doi.org\/10.1101\/gr.171322.113","journal-title":"Genome Research"},{"key":"11221_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioelechem.2022.108216","volume":"147","author":"M Scuderi","year":"2022","unstructured":"Scuderi, M., Dermol-\u010cerne, J., Amaral da Silva, C., Muralidharan, A., Boukany, P. E., & Rems, L. (2022). Models of electroporation and the associated transmembrane molecular transport should be revisited. Bioelectrochemistry, 147, Article 108216. https:\/\/doi.org\/10.1016\/j.bioelechem.2022.108216","journal-title":"Bioelectrochemistry"},{"key":"11221_CR52","unstructured":"Kenny Moore, C., Martin, J., & William, S. (2017). Electroporation of human pluripotent or embryonic stem cells with CRISPR reagents Ribonucleoprotein delivery using the Alt-R \u00ae CRISPR-Cas9 System for homology-directed repair or other genome editing applications. Integrated DNA Technologies (IDT)."},{"key":"11221_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100965","volume":"2","author":"H Xu","year":"2021","unstructured":"Xu, H., Kita, Y., Bang, U., Gee, P., & Hotta, A. (2021). Optimized electroporation of CRISPR-Cas9\/gRNA ribonucleoprotein complex for selection-free homologous recombination in human pluripotent stem cells. STAR Protocols, 2, Article 100965. https:\/\/doi.org\/10.1016\/j.xpro.2021.100965","journal-title":"STAR Protocols"},{"key":"11221_CR54","doi-asserted-by":"publisher","first-page":"5A81","DOI":"10.1002\/9780470151808.sc05a08s35","volume":"2015","author":"SM Byrne","year":"2015","unstructured":"Byrne, S. M., & Church, G. M. (2015). CRISPR-mediated gene targeting of human induced pluripotent stem cells. Current Protocols In Stem Cell Biology, 2015, 5A81\u20135A822. https:\/\/doi.org\/10.1002\/9780470151808.sc05a08s35","journal-title":"Current Protocols In Stem Cell Biology"},{"key":"11221_CR55","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nature17664","volume":"533","author":"D Paquet","year":"2016","unstructured":"Paquet, D., Kwart, D., Chen, A., Sproul, A., Jacob, S., Teo, S., Olsen, K. M., Gregg, A., Noggle, S., & Tessier-Lavigne, M. (2016). Efficient introduction of specific homozygous and heterozygous mutations using CRISPR\/Cas9. Nature, 533, 125\u2013129. https:\/\/doi.org\/10.1038\/nature17664","journal-title":"Nature"},{"key":"11221_CR56","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nbt.3481","volume":"34","author":"CD Richardson","year":"2016","unstructured":"Richardson, C. D., Ray, G. J., DeWitt, M. A., Curie, G. L., & Corn, J. E. (2016). Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA. Nature Biotechnology, 34, 339\u2013344. https:\/\/doi.org\/10.1038\/nbt.3481","journal-title":"Nature Biotechnology"},{"key":"11221_CR57","doi-asserted-by":"publisher","DOI":"10.1093\/gbe\/evab141","volume":"13","author":"SF Bailey","year":"2021","unstructured":"Bailey, S. F., Morales, L. A. A., & Kassen, R. (2021). Effects of synonymous mutations beyond codon bias: The evidence for adaptive synonymous substitutions from microbial evolution experiments. Genome Biology and Evolution, 13, Article evab141. https:\/\/doi.org\/10.1093\/gbe\/evab141","journal-title":"Genome Biology and Evolution"},{"key":"11221_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2022.108444","author":"A Sarkar","year":"2022","unstructured":"Sarkar, A., Panati, K., & Narala, V. R. (2022). Code inside the codon: The role of synonymous mutations in regulating splicing machinery and its impact on disease. Mutation Research\/Reviews in Mutation Research. https:\/\/doi.org\/10.1016\/j.mrrev.2022.108444","journal-title":"Mutation Research\/Reviews in Mutation Research"},{"key":"11221_CR59","unstructured":"Integrated DNA Technologies (IDT). (2021). Alt-R HDR design tool and templates. Integrated DNA Technologies (IDT)."},{"key":"11221_CR60","unstructured":"Integrated DNA Technologies (IDT). (2025). Alt-R\u2122 HDR Enhancer Protein. Integrated DNA Technologies (IDT)."},{"key":"11221_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.stemcr.2019.12.004","volume":"14","author":"S Assou","year":"2020","unstructured":"Assou, S., Girault, N., Plinet, M., Bouckenheimer, J., Sansac, C., Combe, M., Miann\u00e9, J., Bourguignon, C., Fieldes, M., Ahmed, E., et al. (2020). Recurrent Genetic Abnormalities in Human Pluripotent Stem Cells: Definition and Routine Detection in Culture Supernatant by Targeted Droplet Digital PCR. Stem Cell Reports, 14, 1\u20138. https:\/\/doi.org\/10.1016\/j.stemcr.2019.12.004","journal-title":"Stem Cell Reports"},{"key":"11221_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-00292-z","author":"J Halliwell","year":"2020","unstructured":"Halliwell, J., Barbaric, I., & Andrews, P. W. (2020). Acquired genetic changes in human pluripotent stem cells: Origins and consequences. Nature Reviews Molecular Cell Biology. https:\/\/doi.org\/10.1038\/s41580-020-00292-z","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"11221_CR63","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.stem.2010.06.018","volume":"7","author":"M Ohgushi","year":"2010","unstructured":"Ohgushi, M., Matsumura, M., Eiraku, M., Murakami, K., Aramaki, T., Nishiyama, A., Muguruma, K., Nakano, T., Suga, H., Ueno, M., et al. (2010). Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells. Cell Stem Cell, 7, 225\u2013239. https:\/\/doi.org\/10.1016\/j.stem.2010.06.018","journal-title":"Cell Stem Cell"},{"key":"11221_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2023.102629","volume":"4","author":"SP Mojica-Perez","year":"2023","unstructured":"Mojica-Perez, S. P., Stokes, K., Jaklic, D. C., Jahagirdar, S., Uhler, M., Parent, J. M., & Niu, W. (2023). Protocol for selecting single human pluripotent stem cells using a modified micropipetter. STAR Protocols, 4, Article 102629. https:\/\/doi.org\/10.1016\/j.xpro.2023.102629","journal-title":"STAR Protocols"},{"key":"11221_CR65","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2023.2225701","author":"H Ozawa","year":"2023","unstructured":"Ozawa, H., Matsumoto, T., & Nakagawa, M. (2023). Culturing human pluripotent stem cells for regenerative medicine. Expert Opinion on Biological Therapy. https:\/\/doi.org\/10.1080\/14712598.2023.2225701","journal-title":"Expert Opinion on Biological Therapy"},{"key":"11221_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-023-03327-2","volume":"14","author":"E Frank","year":"2023","unstructured":"Frank, E., Cailleret, M., Nelep, C., Fragner, P., Polentes, J., Herardot, E., Kassar, E., Giraud-Triboult, L., Monville, K., C., and, Ben, M., & Barek, K. (2023). Semi-automated optimized method to isolate CRISPR\/Cas9 edited human pluripotent stem cell clones. Stem Cell Research & Therapy, 14, 1\u201314. https:\/\/doi.org\/10.1186\/s13287-023-03327-2","journal-title":"Stem Cell Research & Therapy"},{"key":"11221_CR67","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nbt1310","volume":"25","author":"K Watanabe","year":"2007","unstructured":"Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya, T., Takahashi, J. B., Nishikawa, S., Nishikawa, S. I., Muguruma, K., et al. (2007). A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nature Biotechnology, 25, 681\u2013686. https:\/\/doi.org\/10.1038\/nbt1310","journal-title":"Nature Biotechnology"},{"key":"11221_CR68","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.stemcr.2017.05.021","volume":"9","author":"E N\u00e4rv\u00e4","year":"2017","unstructured":"N\u00e4rv\u00e4, E., Stubb, A., Guzm\u00e1n, C., Blomqvist, M., Balboa, D., Lerche, M., Saari, M., Otonkoski, T., & Ivaska, J. (2017). A strong contractile actin fence and large adhesions direct human pluripotent colony morphology and adhesion. Stem Cell Reports, 9, 67\u201376. https:\/\/doi.org\/10.1016\/j.stemcr.2017.05.021","journal-title":"Stem Cell Reports"},{"key":"11221_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/srep42138","author":"SI Vernardis","year":"2017","unstructured":"Vernardis, S. I., Terzoudis, K., Panoskaltsis, N., & Mantalaris, A. (2017). Human embryonic and induced pluripotent stem cells maintain phenotype but alter their metabolism after exposure to ROCK inhibitor. Scientific Reports. https:\/\/doi.org\/10.1038\/srep42138","journal-title":"Scientific Reports"},{"key":"11221_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.101680","author":"A Caillaud","year":"2022","unstructured":"Caillaud, A., L\u00e9v\u00eaque, A., Th\u00e9drez, A., Girardeau, A., Canac, R., Bray, L., Baudic, M., Barc, J., Gaborit, N., Lamirault, G., et al. (2022). FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells. STAR Protocols. https:\/\/doi.org\/10.1016\/j.xpro.2022.101680","journal-title":"STAR Protocols"},{"key":"11221_CR71","doi-asserted-by":"publisher","unstructured":"Scherzinger, J., T\u00fcrk, D., and Aprile-Garcia, F. (2022). An optimized and validated workflow for developing stable producer cell lines with >99.99% assurance of clonality and high clone recovery. bioRxiv. https:\/\/doi.org\/10.1101\/2022.12.16.520697.","DOI":"10.1101\/2022.12.16.520697."},{"key":"11221_CR72","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.celrep.2016.02.018","volume":"14","author":"JB Renaud","year":"2016","unstructured":"Renaud, J. B., Boix, C., Charpentier, M., De Cian, A., Cochennec, J., Duvernois-Berthet, E., Perrouault, L., Tesson, L., Edouard, J., Thinard, R., et al. (2016). Improved genome editing efficiency and flexibility using modified oligonucleotides with TALEN and CRISPR-Cas9 nucleases. Cell Reports, 14, 2263\u20132272. https:\/\/doi.org\/10.1016\/j.celrep.2016.02.018","journal-title":"Cell Reports"},{"key":"11221_CR73","doi-asserted-by":"publisher","first-page":"9252","DOI":"10.1093\/nar\/gky512","volume":"46","author":"SV Prykhozhij","year":"2018","unstructured":"Prykhozhij, S. V., Fuller, C., Steele, S. L., Veinotte, C. J., Razaghi, B., Robitaille, J. M., McMaster, C. R., Shlien, A., Malkin, D., & Berman, J. N. (2018). Optimized knock-in of point mutations in zebrafish using CRISPR\/Cas9. Nucleic Acids Research, 46, 9252. https:\/\/doi.org\/10.1093\/nar\/gky512","journal-title":"Nucleic Acids Research"},{"key":"11221_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39142-0","volume":"9","author":"AR O\u2019Brien","year":"2019","unstructured":"O\u2019Brien, A. R., Wilson, L. O. W., Burgio, G., & Bauer, D. C. (2019). Unlocking HDR-mediated nucleotide editing by identifying high-efficiency target sites using machine learning. Scientific Reports, 9, Article 2788. https:\/\/doi.org\/10.1038\/s41598-019-39142-0","journal-title":"Scientific Reports"},{"key":"11221_CR75","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2004832117","volume":"118","author":"G Alanis-Lobato","year":"2021","unstructured":"Alanis-Lobato, G., Zohren, J., McCarthy, A., Fogarty, N. M. E., Kubikova, N., Hardman, E., Greco, M., Wells, D., Turner, J. M. A., & Niakan, K. K. (2021). Frequent loss of heterozygosity in CRISPR-Cas9-edited early human embryos. Proceedings of the National Academy of Sciences of the United States of America, 118, Article e2004832117. https:\/\/doi.org\/10.1073\/pnas.2004832117","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"11221_CR76","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1016\/j.molcel.2025.10.015","volume":"85","author":"SB Regan","year":"2025","unstructured":"Regan, S. B., Medhi, D., Xu, Y., White, T. B., Jiang, Y. Z., Kim, J. E., Wang, S. C., Deng, Q., Jia, S., Baasan, D., et al. (2025). Megabase-scale loss of heterozygosity provoked by CRISPR-Cas9 DNA double-strand breaks. Molecular Cell, 85, 4119-4137e.e10. https:\/\/doi.org\/10.1016\/j.molcel.2025.10.015","journal-title":"Molecular Cell"},{"key":"11221_CR77","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.stemcr.2022.02.008","volume":"17","author":"D Simkin","year":"2022","unstructured":"Simkin, D., Papakis, V., Bustos, B. I., Ambrosi, C. M., Ryan, S. J., Baru, V., Williams, L. A., Dempsey, G. T., McManus, O. B., Landers, J. E., et al. (2022). Homozygous might be hemizygous: CRISPR\/Cas9 editing in iPSCs results in detrimental on-target defects that escape standard quality controls. Stem Cell Reports, 17, 993\u20131008. https:\/\/doi.org\/10.1016\/j.stemcr.2022.02.008","journal-title":"Stem Cell Reports"},{"key":"11221_CR78","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.stemcr.2015.04.001","volume":"4","author":"R Siller","year":"2015","unstructured":"Siller, R., Greenhough, S., Naumovska, E., & Sullivan, G. J. (2015). Small-molecule-driven hepatocyte differentiation of human pluripotent stem cells. Stem Cell Reports, 4, 939\u2013952. https:\/\/doi.org\/10.1016\/j.stemcr.2015.04.001","journal-title":"Stem Cell Reports"},{"key":"11221_CR79","doi-asserted-by":"publisher","DOI":"10.1002\/cpsc.13","author":"S Mathapati","year":"2016","unstructured":"Mathapati, S., Siller, R., Impellizzeri, A. A. R., Lycke, M., Vegheim, K., Almaas, R., & Sullivan, G. J. (2016). Small-molecule-directed hepatocyte-like cell differentiation of human pluripotent stem cells. Current Protocols in Stem Cell Biology. https:\/\/doi.org\/10.1002\/cpsc.13","journal-title":"Current Protocols in Stem Cell Biology"},{"key":"11221_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/srep37178","volume":"6","author":"R Siller","year":"2016","unstructured":"Siller, R., Naumovska, E., Mathapati, S., Lycke, M., Greenhough, S., & Sullivan, G. J. (2016). Development of a rapid screen for the endodermal differentiation potential of human pluripotent stem cell lines. Scientific Reports, 6, Article 37178. https:\/\/doi.org\/10.1038\/srep37178","journal-title":"Scientific Reports"},{"key":"11221_CR81","doi-asserted-by":"publisher","first-page":"1G.7.1","DOI":"10.1002\/cpsc.36","volume":"43","author":"R Siller","year":"2017","unstructured":"Siller, R., & Sullivan, G. J. (2017). Rapid screening of the endodermal differentiation potential of human pluripotent stem cells. Current Protocols in Stem Cell Biology, 43, 1G.7.1-1G.7.23. https:\/\/doi.org\/10.1002\/cpsc.36","journal-title":"Current Protocols in Stem Cell Biology"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11221-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-026-11221-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11221-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:02:21Z","timestamp":1793300541000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-026-11221-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":81,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["11221"],"URL":"https:\/\/doi.org\/10.1007\/s12015-026-11221-6","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to remove Supplementary File 2 (DOCX), retain the PDF and Excel supplementary files, and update the Graphical Abstract.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The use of patient material was approved by the Norwegian regional committees for medical and health research ethics (REK 2018\/777) and the Data Protection Officer at Oslo University Hospital (PVO #18\/20935), after informed consent was obtained. The patient-derived iPSCs were generated from peripheral blood mononuclear cells (PBMCs), as described in Roman et al., 2026 [\n                      \n                      ].","order":1,"name":"Ethics","label":"Ethical considerations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}